Becton, Dickinson and Co. | BDX - Gross Profit On Sales

Stock Price
210.02
Daily Change
3.51 1.70%
Monthly
3.61%
Yearly
-8.63%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $696M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Agilent USD 990M 102M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Avanos Medical USD 86M 6.1M Sep/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 441M 49M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Globus Medical USD 486.67M 725.06M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Medtronic USD 5.44B 123M Sep/2025
Solventum Corp USD 1.14B 40M Sep/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 134.29M 8.44M Sep/2025
Teleflex USD 451.64M 20.56M Sep/2025
Terumo JPY 147B 1.53B Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025